PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia

dc.creatorPrieto, VA
dc.creatorReyes, JM
dc.creatorLopez-Cabra, C
dc.creatorDiaz, JA
dc.creatorUrrego-Novoa
dc.date.accessioned2020-08-06T16:20:25Z
dc.date.accessioned2022-09-22T13:49:20Z
dc.date.available2020-08-06T16:20:25Z
dc.date.available2022-09-22T13:49:20Z
dc.date.created2020-08-06T16:20:25Z
dc.identifierISSN: 1098-3015
dc.identifierEISSN: 1524-4733
dc.identifierhttps://repository.urosario.edu.co/handle/10336/25997
dc.identifierhttps://doi.org/10.1016/j.jval.2016.03.1586
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3432902
dc.description.abstractTo estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.
dc.languageeng
dc.publisherElsevier
dc.relationValue in Health, ISSN: 1098-3015 ; EISSN: 1524-4733, Vol.19, No.3 (May, 2016); pp.a149
dc.relationhttps://www.valueinhealthjournal.com/article/S1098-3015(16)01654-5/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301516016545%3Fshowall%3Dtrue
dc.relationNo. 3
dc.relationa149
dc.relationValue in Health
dc.relationVol. 19
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.rightsRestringido (Acceso a grupos específicos)
dc.sourceValue in Health
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.titlePCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
dc.typearticle


Este ítem pertenece a la siguiente institución